As of 06 Nov 2026 04:34 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from the latest notice (08 Nov 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Update: (08/11/2021) This productaffected product · inferred from phrasing | Discontinued, as stated | — not stated for this line | notice of 08 Nov 2021 |
| DDAVP (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solutionaffected product · inferred from phrasing | Out of stock, as stated | — not stated for this line | notice of 08 Nov 2021 |
| Desmopressin tablets and oral lyophilisatesnamed by the source as remaining available · inferred from phrasing · its own page → | Stated as available | — not stated for this line | notice of 08 Nov 2021 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Desmopressin tablets and oral lyophilisates — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Ddavp
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 08 Nov 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 08 Nov 2021 | Medicine Supply Notification: DDAVP (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solution - Updated | Supply notification | — | — |
Also recorded under
Bracketed names seen in this medicine's notice titles: desmopressin. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)10 Desmopressin 10microgram/dose nasal spray · issued 26 Mar 2025 · valid until early September 2025, as stated · matched by the recorded name “desmopressin” PDF ↗
- MSAN(2024)45 Desmopressin (DDAVP®) 4 micrograms/1ml solution for injection ampoules · issued 05 Aug 2024 · valid until w/c 16th September, as stated · matched by name PDF ↗
- MSAN(2021)10 Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring · issued 08 Mar 2021 · valid until Q3 of 2023 - update to MSAN(2020)95, as stated · matched by the recorded name “desmopressin” PDF ↗
- MSAN(2020)101 DDAVP® (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solution · issued 21 Oct 2020 · valid until mid-2021, as stated · matched by name PDF ↗
- MSAN(2020)95 Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring · issued 09 Oct 2020 · valid until mid-2021, as stated · matched by the recorded name “desmopressin” PDF ↗